Functional Modulation of Dendritic Cells by Milatuzumab, a Humanized Anti-CD74 Monoclonal Antibody

被引：0

作者：

Chen, Xiaochuan ^{[1
]}

Chang, Ken ^{[1
]}

Goldenberg, David M. ^{[1
]}

机构：

[1] Immunomed Inc, Morris Plains, NJ USA

来源：

JOURNAL OF IMMUNOTHERAPY | 2008年 / 31卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：955 / 955

页数：1

共 50 条

[1] Efficient Binding, but Moderate Modulation, of Human Dendritic Cell Functions by Milatuzumab, a Humanized Anti-CD74 Monoclonal Antibody
Chen, Xiaochuan
Chang, Chien-Hsing
Goldenberg, David
[J]. BLOOD, 2008, 112 (11) : 916 - 916
[2] Dose-escalation trial of milatuzumab (humanized anti-CD74 monoclonal antibody) in multiple myeloma
Kaufman, J. L.
Niesvizky, R.
Stadtmauer, E. A.
Chanan-Khan, A.
Siegel, D.
Horne, H.
Teoh, N.
Wegener, W. A.
Goldenberg, D. M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[3] First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma.
Kaufman, Jonathan
Niesvizky, Ruben
Stadtmauer, Edward A.
Chanan-Khan, Asher
Siegel, David
Home, Heather
Teoh, Nick
Leoni, Matthew J.
Wegener, William A.
Goldenberg, David M.
[J]. BLOOD, 2008, 112 (11) : 1266 - 1267
[4] Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma
Kaufman, Jonathan L.
Niesvizky, Ruben
Stadtmauer, Edward A.
Chanan-Khan, Asher
Siegel, David
Horne, Heather
Wegener, William A.
Goldenberg, David M.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) : 478 - 486
[5] Prevention of Acute Graft-Versus-Host Disease in Human/Mouse Xenogeneic SCID Mouse Model by Humanized Anti-CD74 Monoclonal Antibody, Milatuzumab
Chen, Xiaochuan
Chang, Chien-Hsing
Stein, Rhona
Cardillo, Thomas M.
Gold, David V.
Goldenberg, David M.
[J]. BLOOD, 2012, 120 (21)
[6] Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Alinari, Lapo
Yu, Bo
Christian, Beth A.
Yan, Fengting
Shin, Jungook
Lapalombella, Rosa
Hertlein, Erin
Lustberg, Mark E.
Quinion, Carl
Zhang, Xiaoli
Lozanski, Gerard
Muthusamy, Natarajan
Praetorius-Ibba, Mette
O'Connor, Owen A.
Goldenberg, David M.
Byrd, John C.
Blum, Kristie A.
Baiocchi, Robert A.
[J]. BLOOD, 2011, 117 (17) : 4530 - 4541
[7] The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
Christian, Beth A.
Poi, Ming
Jones, Jeffrey A.
Porcu, Pierluigi
Maddocks, Kami
Flynn, Joseph M.
Benson, Don M.
Phelps, Mitch A.
Wei, Lai
Byrd, John C.
Wegener, William A.
Goldenberg, David M.
Baiocchi, Robert A.
Blum, Kristie A.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 701 - 710
[8] Prevention of Acute Graft-versus-Host Disease in a Xenogeneic SCID Mouse Model by the Humanized Anti-CD74 Antagonistic Antibody Milatuzumab
Chen, Xiaochuan
Chang, Chien-Hsing
Stein, Rhona
Cardillo, Thomas M.
Gold, David V.
Goldenberg, David M.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : 28 - 39
[9] Milatuzumab (humanized anti-CD74 mAb) targets and kills B-cell malignancies, and blocks signal transduction through CD74
Stein, Rhona
Karacay, Habibe
Sharkey, Robert
Smith, Mitchell
Goldenberg, David
[J]. CANCER RESEARCH, 2009, 69
[10] A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
Christian, Beth
Alinari, Lapo
Earl, Christian Tyler
Wilding, Emily
Quinion, Carl
Lustberg, Mark
Benson, Don M., Jr.
Jones, Jeffrey A.
Byrd, John C.
Wegener, William A.
Goldenberg, David M.
Baiocchi, Robert A.
Blum, Kristie A.
[J]. BLOOD, 2010, 116 (21) : 1148 - 1149

← 1 2 3 4 5 →